UniSA BackOff! Study: Adelaide PrenaBelt Trial
NCT04437407 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2021-09-02
Summary
Stillbirth (SB) is a devastating complication of pregnancy and contributes to over 2 million deaths globally every year. Over 20 million infants are born every year with low birth weight (LBW), which is associated with a twenty times increased risk of death in the first year of life and high rates of short- and long-term illnesses. Sleeping on one's back during pregnancy has recently emerged as a potential risk factor for LBW and SB in the medical literature. In high-income countries, SB rates have mostly remained the same in the past two decades and targeting modifiable risk factors could help reduce the number of SB and LBW in the population.
When a pregnant woman sleeps on her back, her body position compresses underlying blood vessels and reduces blood flow to the developing baby. This body position could cause unpleasant symptoms for the mother and result in LBW or SB of her baby. Lying on her side or with a slight lateral tilt helps relieve this compression. One way to keep people off their back while sleeping is by using positional therapy (PT). It is a simple, safe, inexpensive and effective intervention for preventing people who snore or people who's breathing pauses during sleep from sleeping on their back. Reducing the amount of time pregnant women sleep on their back could help reduce SB and LBW rates. The investigators developed a PT device (PrenaBelt) and tested it in three clinical trials, which demonstrated that it significantly decreases the number of time women spend sleeping on their back. Using feedback from our previous research, the investigators developed five additional devices that will be tested in this study.
The purpose of this study is to evaluate the new PrenaBelt (PB2) prototypes' ability to reduce the amount of time pregnant women sleep on their backs in the third trimester of pregnancy, validate the Ajuvia Sleep Monitor, and collect feedback on the devices.
Demonstrating that the sleeping position of pregnant women can be modified through the use of a simple, inexpensive PT intervention may be one of the keys to achieving significant reductions in LBW and late SB rates in Australia and worldwide.
Conditions
- Stillbirth
- Infant, Low Birth Weight
- Infant, Very Low Birth Weight
- Sleep-Disordered Breathing
- Infant, Small for Gestational Age
- Fetal Hypoxia
- Pregnancy Complications
- Fetal Growth Retardation
Interventions
- DEVICE
-
PB2-1 prototype
PB2-1 prototype is a belt-like wearable device similar to the original PrenaBelt designed for pregnant women that permits supine positioning of the pelvis but, when in this position, provides subtle pressure points to the user's body and thereby activates the body's natural mechanism to reposition itself to relieve discomfort. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.
- DEVICE
-
PB2-2 prototype
PB2-2 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.
- DEVICE
-
PB2-3 prototype
PB2-3 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.
- DEVICE
-
PB2-4 prototype
PB2-4 prototype is a belt-like wearable device designed for pregnant women that prevents the user from achieving a supine position as the device allows right and left lateral pelvic tilt but prevents the user's pelvis from settling supine due to virtue of its design. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.
- DEVICE
-
PB2-5 prototype
PB2-5 prototype is a belt-like wearable device designed for pregnant women that does not provide positional therapy. It can be worn anytime as a maternity support belt.
- DEVICE
-
Ajuvia-Active
Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the active mode, it alerts the woman when her pelvis is in the supine position through a gentle vibratory alarm.
- DEVICE
-
Ajuvia-Passive
Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the passive mode, it measures and records the position of the pelvis but does not alert the woman.
Sponsors & Collaborators
-
University of South Australia
collaborator OTHER -
Shiphrah Biomedical Inc.
lead INDUSTRY
Principal Investigators
-
Jane Warland, PhD · University of South Australia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2021-06-10
- Completion
- 2021-06-15
Countries
- Australia
Study Locations
More Related Trials
-
Saccadic Reaction Time and Preterm Pre-eclampsia
NCT02613793 ·Status: TERMINATED
-
Precision Medicine for Preterm Birth
NCT02173210 ·Status: COMPLETED
-
Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia
NCT02881073 ·Status: COMPLETED ·Phase: NA
-
Prenatal Pilates and Postpartum Ligamentous Laxity
NCT07344857 ·Status: COMPLETED
-
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
NCT01545674 ·Status: TERMINATED
-
Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia
NCT04474704 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
NCT02883673 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth
NCT02092688 ·Status: COMPLETED
-
Placental Vasculature for Prediction of Recurrent Fetal Growth Restriction
NCT04399174 ·Status: COMPLETED
-
Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery
NCT01404910 ·Status: COMPLETED ·Phase: NA
-
The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study
NCT04179487 ·Status: UNKNOWN
-
Effects of ACS in Twin With LPB: Study Protocol for a RCT
NCT03547791 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impedance Cardiography to Decrease the Risk of Preeclampsia
NCT03245970 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Validity and Feasibility of the Pregnancy Monitoring Belt - a Clinical Pilot Study
NCT06683170 ·Status: NOT_YET_RECRUITING
-
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies
NCT05945446 ·Status: COMPLETED
-
Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
NCT02702999 ·Status: COMPLETED ·Phase: NA
-
Maternal Left Lateral Position in Fetal Growth Restriction
NCT06919692 ·Status: RECRUITING ·Phase: NA
-
Placental Volume, Flow, and Vascularity Study
NCT04900207 ·Status: COMPLETED
-
Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure
NCT01029691 ·Status: COMPLETED ·Phase: NA
-
Study of the Effectiveness of Osteopathic Manipulative Treatment in Pregnant Women
NCT00298935 ·Status: COMPLETED ·Phase: PHASE2
-
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866 ·Status: RECRUITING ·Phase: NA
-
Sonographic Prediction of Preterm Delivery Between 24-34 Weeks of Gestation
NCT00613210 ·Status: UNKNOWN
-
A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months
NCT07282171 ·Status: RECRUITING ·Phase: PHASE1
-
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240 ·Status: COMPLETED ·Phase: NA